A novel vaccine platform has been developed to induce broad, protective immunity against numerous influenza virus infections, ...
Third-party research conducted by leading U.S. academic institutions published in a peer reviewed journal Frontiers in Immunology shows a favorable safety profile for intranasally administered ...
The need for more effective protection against influenza continues to grow, as the virus consistently causes significant illness and mortality worldwide New human clinical data from Leyden Labs show ...
Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the launch of preclinical studies for an intranasal delivery system for Benzodiazepines, aiming to improve treatment options ...
Background and Objective: Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and vomiting during attacks may limit the usefulness of oral medications. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results